Clinical Trials Logo

Filter by:
NCT ID: NCT05993312 Recruiting - Clinical trials for All Adult Patients Admitted to theHMPIT ICU for Management of Head Trauma

Quality of Life in Traumatic Brain Injury Patients

Start date: June 1, 2023
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to describe the quality of life of CT patients in our study, at least 6 months after the occurrence of the trauma. This assessment is related to the patient's degree of sequelae, using the GOSE scale.

NCT ID: NCT05991089 Recruiting - Hypertension Clinical Trials

Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients

TUN-CKDH
Start date: January 8, 2024
Phase:
Study type: Observational [Patient Registry]

In Tunisia, high blood pressure (HTN) is a public health problem whose prevalence varies from 28.7% to 34.7%. Hypertension can be both, cause and consequence of chronic kidney disease, and its prevalence is quite high in this population. It is both a risk factor for mortality and cardiovascular morbidity, but also a major cause of terminal chronic kidney disease becoming an additional public health concern. Detecting and diagnosing chronic kidney in all hypertensives at an early stage remains a global public health challenge. A well-conducted treatment makes it possible to reach the blood pressure objective but also to reduce the risk of occurrence of a cardiovascular event and to slow the progression of chronic kidney disease. In Tunisia, few data exists concerning the prevalence of chronic kidney disease in hypertensive subjects, thus limiting the development and elaboration of preventive measures. A national survey will thus be conducted by the "Kidney and Metabolic Diseases" Working Group under the aegis of the Tunisian Society of Nephrology, Dialysis and Kidney Transplantation. The main objective is to estimate the prevalence of chronic kidney disease in hypertensive tunisian patients.

NCT ID: NCT05968014 Completed - Clinical trials for Enhanced Recovery After Surgery

Quality of Recovery After Hip Fracture Surgery: US-guided PENG Block Versus FICB

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Patients were randomly divided into two groups to receive either ultrasound-guided pericapsular nerve group block (PENG group) or fascia iliaca compartment block (FICB group), using 20 ml of 0.2% ropivacaine

NCT ID: NCT05886283 Completed - Clinical trials for Effect of Cataract Surgery on Corneal Endothelium; About 2 Techniques

Qualitative and Quantitative Endothelium Changes After Cataract Surgery: Ultrasound Phacoemulsification vs Nanolaser Technique

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

Purpose: The aim of this study was to evaluate corneal endothelial cell density and morphology, central corneal thickness, and best visual acuity using US phacoemulsification or Nanosecond laser technique. Setting: Department of ophthalmology, Nabeul, Tunisia. Design: Prospective cohort study. Methods: The study included eyes with nuclear cataract density grade 1, 2, 3, or 4 according to LOCS III, divided into two groups; Group 1 had conventional US, and group 2 had nanosecond laser. The Endothelial Cell Density (ECD), coefficient of variation (CoV) in cell size, percentage of hexagonal cells, central corneal thickness and best visual acuity were evaluated over 24 months.

NCT ID: NCT05874583 Completed - Clinical trials for Arthroplasty, Replacement, Knee

Prevention of Bleeding in Total Joint Replacement: Combined Route Administration of Tranexamic Acid

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The investigators aimed to compare two doses of intravenous (IV) tranexamic acid (TXA) with a combined single dose of topical and IV TXA on haemoglobin decline 24 hours after total joint arthroplasties. The investigators conducted randomized, double-blind trial. The participants were randomized to either intrvenous group receiving 2 doses of 1 gram TXA in intravenous route 3 hours apart, or a combined application group receiving the first 1 gram IV and the topical dose was 1.5 gram after reduction of the fascia.

NCT ID: NCT05874531 Completed - Ultrasonography Clinical Trials

End-expiratory Occlusion Test and Prediction of Preload Dependence

Start date: May 15, 2023
Phase:
Study type: Observational

Three sets of measurements of hemodynamic parameters and sub-aortic VTI were performed: before and at the end of 15 seconds end-expiratory occlusion and after 250 mL saline administration over 10 minutes. Patients were considered responders to fluid loading after an increase in sub-aortic VTI of more than 10% following a volume expansion. SPSS was used for statistic study. A p < 0.05 was considered significant. The investigators performed univariate and then multivariate analysis.

NCT ID: NCT05871138 Recruiting - Emergencies Clinical Trials

Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure

Deltalus
Start date: March 30, 2023
Phase:
Study type: Observational [Patient Registry]

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

NCT ID: NCT05871073 Completed - Clinical trials for Lumbar Spinal Stenosis

Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery

Start date: January 1, 2023
Phase: Phase 4
Study type: Interventional

Introduction: Improving postoperative pain management after spinal surgery is a significant challenge for surgeons and anesthesiologists. Pain following spinal surgery, can lead to significant morbidity, limit early mobility, and increase the risk of chronic pain. This trial examines the analgesic effects of dexamethasone as an adjuvant to ropivacaine in wound infiltration after lumbar surgery. Methods: In this study, we randomly assigned sixty patients undergoing lumbar laminectomy and/or osteosynthesis into two groups of 30 patients each. The control group (R-group) received only Ropivacaine (150 mg of Ropivacaine 7.5% (20 ml) added to 2 ml of normal saline in the wound infiltration), while the intervention group (RD-group) received Ropivacaine with the addition of dexamethasone (150 mg of Ropivacaine 7.5% (20 ml) added to 8 mg of dexamethasone in the wound infiltration). Both groups were administered patient-controlled analgesia (PCA) with morphine for self-medication. Postoperatively, a blinded evaluator assessed pain at H0, recorded the assessment of surgical scar pain using the Visual Analog Scale (VAS) at 4, 6, 12, 24, and 48 hours, as well as the time to the first opioid request, cumulative morphine consumption, opioid-related side effects, and length of stay. All patients were scheduled for a 3-month follow-up call to monitor chronic pain progression.

NCT ID: NCT05869214 Recruiting - Heart Failure Clinical Trials

Middle East African Registry Women CardioVascular Disease

MEA-WCVD
Start date: May 10, 2023
Phase:
Study type: Observational [Patient Registry]

The MEA cardiology societies have joined forces to tackle the issue by establishing a tangible real-world data registry in every MEA country. This endeavor has resulted in the development of a multicenter registry called MEA-WCVD, which is being sponsored by each national cardiology society from participating countries. All data gathered will be consolidated into a singular registry for thorough analysis. Country specific analysis will be performed.

NCT ID: NCT05868317 Active, not recruiting - Rectal Cancer Clinical Trials

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Start date: November 1, 2020
Phase: Phase 2
Study type: Interventional

A Single-arm phase II trial evaluating induction chemotherapy with FOLFIRINOXm followed by short course radiotherapy (RT) in locally advanced rectal carcinoma